Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT00831597

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Pharmatech Oncology Study Site Beverly Hills, California, United States
  • Pharmatech Oncology Study Site Fountain Valley, California, United States
  • Pharmatech Oncology Study Site Oxnard, California, United States
  • Pharmatech Oncology Study Site Washington D.C., District of Columbia, United States
View all 33 locations
View Trial Details
Completed

Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma

NCT01369784

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hospital de Elda Elda, Alicante, Spain
  • H. U. Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Clinic i Provincial Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
View all 56 locations
View Trial Details
Completed

A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib

NCT01324596

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Kantonsspital Liestal Basel, Switzerland
  • Universitatsspital Basel Basel, Switzerland
  • Ospedale Regionale Bellinzona e Valli (IOSI) Bellinzona, Switzerland
View all 109 locations
View Trial Details
Completed

Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

NCT00765245

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

NCT00107380

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Piedmont Hospital Atlanta, Georgia, United States
View all 78 locations
View Trial Details

Related conditions